Biokloot schreef op 19 december 2023 17:58:
Goed nieuws ....... eindejaars geschenk ......
Creation of New Share Option Plan
Liege, Belgium, 19 December 2023 – 17:45 CEST – Mithra Pharmaceuticals SA (the
"Company" or "Mithra") (Euronext Brussels: MITRA), a company dedicated to Women’s
Health, today announces that its board of directors has issued, within the framework of the
authorised capital, a new share option plan for eligible personnel, covering 7,615,500 share
options (the "2023 Share Option Plan").
The share options under the 2023 Share Option Plan have a term of ten years (unless
contractually reduced in the grant to a selected participant) and can be exercised in
accordance with the provisions of the 2023 Share Option Plan (the conditions of which can
be found on the Company's website). Each share option gives the right to subscribe for one
new share of the Company. The share options will not be listed on any stock market.
The purpose of the 2023 Share Option Plan is to create a share option plan for eligible
members of the personnel of the Company (defined in accordance with article 1:27 of the
Belgian Companies and Associations Code), taking into account the recent expiration of the
2018 share option plan.
The reports prepared by the board of directors and the Company’s statutory auditor (in
accordance with article 7:198 juncto articles 7:180 and 7:191 of the Belgian Companies and
Associations Code) with respect to the creation of the 2023 Share Option Plan are available
on the Company's website